Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$2.27M Buy
47,195
+3,289
+7% +$162K 0.07% 237
2016
Q3
$2.37M Buy
43,906
+3,479
+9% +$191K 0.08% 227
2016
Q2
$2.19M Buy
40,427
+646
+2% +$34K 0.08% 235
2016
Q1
$2.02M Buy
39,781
+5,662
+17% +$282K 0.08% 237
2015
Q4
$1.72M Buy
34,119
+8,520
+33% +$434K 0.08% 245
2015
Q3
$1.23M Sell
25,599
-833
-3% -$43.4K 0.1% 216
2015
Q2
$1.38M Buy
26,432
+3,142
+13% +$177K 0.1% 231
2015
Q1
$1.34M Buy
23,290
+5,320
+30% +$305K 0.09% 235
2014
Q4
$960K Buy
17,970
+5,440
+43% +$304K 0.1% 220
2014
Q3
$720K Buy
12,530
+5,410
+76% +$332K 0.09% 273
2014
Q2
$476K Buy
7,120
+2,206
+45% +$149K 0.06% 346
2014
Q1
$328K Buy
4,914
+33
+0.7% +$2.23K 0.05% 391
2013
Q4
$326K Buy
+4,881
New +$316K 0.05% 373
2013
Q3
Sell
-2,996
Closed -$187K 2273
2013
Q2
$187K Buy
+2,996
New +$190K 0.04% 435

Other funds holding GSK

MSI Financial Services's GSK Position: Q4 2016 in Review

MSI Financial Services increased its GSK (GSK) stake by 7.5% in Q4 2016, buying an estimated $162K and bringing the position to 47,195 shares worth $2.27M. The position accounts for 0.07% of the portfolio, ranked #237.

MSI Financial Services first reported a position in GSK in Q2 2013 and has held it in 14 quarters since. The position peaked at $2.37M in Q3 2016. 762 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

  • MSI Financial Services held 47,195 shares of GSK worth $2.27M as of Q4 2016.
  • MSI Financial Services bought 3,289 GSK shares in Q4 2016, an estimated $162K.
  • GSK made up 0.07% of MSI Financial Services's portfolio in Q4 2016, its #237 holding.
  • MSI Financial Services first reported a position in GSK in Q2 2013 and has held it in 14 quarters since.
  • MSI Financial Services's GSK position peaked at $2.37M in Q3 2016.
  • 762 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.